Search / Trial NCT06230328

Brazilian Reality of Hepatocellular Carcinoma

Launched by ASTRAZENECA · Jan 19, 2024

Trial Information

Current as of October 04, 2024

Recruiting

Keywords

Hepatocellular Carcinoma; Rwe

Description

Hepatocellular carcinoma is the third leading cause of cancer-related deaths worldwide. Prognosis strongly depends of the underlying liver disease, tumor-specific characteristics such as tumor load, extrahepatic spread and portal vein branch thrombosis, as well as access to treatments. The Brazilian reality of hepatocellular tumor clinical presentation varies widely and the management profile, treatments adopted and response rates are little described. Taking into consideration the heterogeneity of health services in reference centers in Brazil, knowing the epidemiology profile and treatmen...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Male and female;
  • * Above 18 years old;
  • * Hepatocellular carcinoma diagnosis (confirmed by biopsy or imaging);
  • Exclusion Criteria:
  • * Fibrollamelar carcinoma, hepatoblastoma, intrahepatic cholangiocarcinoma, neuroendocrine tumors or other less common types of liver tumors;
  • * Patients with incomplete staging data;
  • * Patients with only 1 visit to the participating site healthcare service, with loss to follow-up prior to the second visit to the participating site healthcare service;
  • * Previous treatment for hepatocellular carcinoma in another institution;
  • * Treatment with investigational drugs in a clinical trial.

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Belo Horizonte, , Brazil

Curitiba, , Brazil

Porto Alegre, , Brazil

Rio De Janeiro, , Brazil

Sao Paulo, , Brazil

Barretos, , Brazil

Florianopolis, , Brazil

Salvador, , Brazil

Recife, , Brazil

Sao Jose Do Rio Preto, , Brazil

Porto Alegre, Rio Grande Do Sul, Brazil

Porto Alegre, Rio Grande Do Sul, Brazil

Porto Alegre, Rio Grande Do Sul, Brazil

São Paulo, , Brazil

Natal, , Brazil

Vitoria, , Brazil

Natal, Rio Grande Do Norte, Brazil

Rio De Janeiro, , Brazil

Recife, Pernambuco, Brazil

Belo Horizonte, Minas Gerais, Brazil

Salvador, Bahia, Brazil

Vitória, Espirito Santo, Brazil

Florianópolis, Santa Catarina, Brazil

Barretos, São Paulo, Brazil

São Paulo, , Brazil

Belo Horizonte, Minas Gerais, Brazil

São José Do Rio Preto, São Paulo, Brazil

São Paulo, , Brazil

São Paulo, , Brazil

São Paulo, , Brazil

Sao Bernardo Do Campo, , Brazil

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0